Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments

QR Code

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments

Saved in:

Bibliographic Details
Main Author:	Nicholas Greig Evans
Format:	article
Language:	EN
Published:	American Society for Microbiology 2014
Subjects:	Microbiology QR1-502
Online Access:	https://doaj.org/article/d7b8ff29b5104fc29df30c6b8b6e077b
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
by: Arturo Casadevall, et al.
Published: (2014)

An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential
by: Arturo Casadevall, et al.
Published: (2014)

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
by: Arturo Casadevall, et al.
Published: (2014)

Reply to “The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards”
by: Michelle Rozo, et al.
Published: (2015)

An Avian H7N1 Gain-of-Function Experiment of Great Concern
by: Simon Wain-Hobson
Published: (2014)

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness
by: S. Schultz-Cherry, et al.
Published: (2014)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
by: Michael J. Imperiale, et al.
Published: (2020)

The Decision to Publish an Avian H7N1 Influenza Virus Gain-of-Function Experiment
by: Terence S. Dermody, et al.
Published: (2014)

Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?
by: Marc Lipsitch
Published: (2014)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
by: Michael J. Imperiale, et al.
Published: (2014)

Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion
by: Arturo Casadevall, et al.
Published: (2014)

Biocontainment in Gain-of-Function Infectious Disease Research
by: W. Ian Lipkin
Published: (2012)

Zika Virus Focuses the Gain-of-Function Debate
by: Michael J. Imperiale, et al.
Published: (2016)

mSphere of Influence: the Value of Simplicity in Experiments and Solidarity among Lab Members
by: Nicholas A. Wallace
Published: (2019)

The Apocalypse as a Rhetorical Device in the Influenza Virus Gain-of-Function Debate
by: Arturo Casadevall, et al.
Published: (2014)

<italic toggle="yes">mBio</italic> Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
by: Arturo Casadevall, et al.
Published: (2014)

Reply to “Conclusive Evidence of Replication of a Plant Virus in Honeybees Is Lacking”
by: Ji Lian Li, et al.
Published: (2014)

Human Infection Challenge Studies: a Test for the Social Value Criterion of Research Ethics
by: Nicholas G. Evans
Published: (2020)

Reply to “The Underestimation of Global Microbial Diversity”
by: Rudolf Amann, et al.
Published: (2016)

The ASM Journals Committee Values the Contributions of Black Microbiologists
by: Patrick D. Schloss, et al.
Published: (2020)

The ASM Journals Committee Values the Contributions of Black Microbiologists
by: Patrick D. Schloss, et al.
Published: (2020)

The ASM Journals Committee Values the Contributions of Black Microbiologists
by: Patrick D. Schloss, et al.
Published: (2020)

The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate
by: Michelle Rozo, et al.
Published: (2015)

Falling down the Rabbit Hole: aTRIP Toward Lexiconic Precision in the “Gain-of-Function” Debate
by: W. Paul Duprex, et al.
Published: (2014)

Reply to “Understanding the Role of Fungi in Chronic Wounds”
by: Lindsay Kalan, et al.
Published: (2016)

Reply to “Precedence for the Structural Role of Flagella in Biofilms”
by: Regine Hengge
Published: (2013)

Reply to “Triclocarban and Health: the Jury Is Still Out”
by: Lauren Pischel, et al.
Published: (2016)

Reply to “Funding by Lottery: Political Problems and Research Opportunities”
by: Arturo Casadevall, et al.
Published: (2016)

The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards
by: Martin Furmanski
Published: (2015)

Reply to “Unrealistic Nonphysiological Amounts of Reagents and a Disregard for Published Literature”
by: Alistair J. P. Brown
Published: (2015)

Reply to “‘Tolerance’ of Misused Terminology? Enforcing Standardized Phenotypic Definitions”
by: Jakob Haaber, et al.
Published: (2015)

Reply to “Statins may decrease the Fatality Rate of MERS Infection”
by: Allison L. Totura, et al.
Published: (2015)

Studies in Epistemology & Theory of Values

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
by: David S. Fedson, et al.
Published: (2016)

Reply to “Improving Microbiology Research: the Problems Are Less Statistical and More Biological”
by: Arturo Casadevall, et al.
Published: (2016)

Erratum for Mortier and Gayán et al., “Gene Erosion Can Lead to Gain-of-Function Alleles That Contribute to Bacterial Fitness”
by: Julien Mortier, et al.
Published: (2021)

Reply to “The Natural Environment May Be the Most Important Source of Antibiotic Resistance Genes”
by: Fabienne Wichmann, et al.
Published: (2014)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
by: Daniel E. Goldberg, et al.
Published: (2017)

Reply to “Concerns about Transmission Electron Micrographs in Recent Article by Chen and Williams”
by: Henry Neal Williams
Published: (2012)

Reply to Jobling, “Lysogeny of Escherichia coli by the Obligately Lytic Bacteriophage T1: Not Proven”
by: Leanid Laganenka, et al.
Published: (2021)